click below
click below
Normal Size Small Size show me how
Lecture 2
Pharmacokinetics I
Question | Answer |
---|---|
Pharmacokinetic principles | once a drug is administered: Absorbed into bloodstream Distributed to site of action Permeate through each compartment Metabolized (liver) Eliminated (kidney) |
Prodrug | inactive precursor chemical that is absorbed and then converted to active drug (clopidogrel for ex.) |
Drug routes for enteral | PO, SL, buccal |
Drug routes for parenteral | IV, IM, SC, ID |
Advantages for parenteral | rapid onset of action; dosing control |
Disadvantages for parenteral | local tissue damage/infections |
IV | rapid effect and max control; bolus; infusion |
IM | aqueous solutions; specialized depot preps; sustained dose over an extended interval |
SC | simple diffusion; minimizes risks seen with IV injection; not recommended for drugs that cause tissue irritation |
Oral | toxicities/overdoses treated with antidotes; disadvantages include pathways involved with drug absorption; enteric-coated preparations; extended-release preparations ER, XR, XL, SR |
ID | used for diagnostic purposes, desensitization |
Inhalation/nasal preps | effects almost as rapid as with IV bolus |
Intrathecal/IV | directly into CSF; local rapid effects |
Topical | used for local effect |
Transdermal | systemic effects; rate of absorption varies, characteristics of skin at application site and lipid solubility of medication |
Rectal | bypasses 50% of portal circulation, minimizing biotransformation of drugs by liver; bypasses GI, absorption erratic and incomplete |
Absorption | administration site into bloodstream; administration routes (not IV) cause partial absorption/lower bioavailability |
Absorption factors | where drug is absorbed; characteristics of drug; route of administration |
Bioavailability | percent of medication that reaches circulation |
Passive Diffusion | high to low concentration; no carrier; not saturable; lipid-soluble go through liid bilayer; water soluble - channel pore |
Special Carriers ** | active transport and facilitated diffusion; ABC (ATP-binding cassette) family: p-glycoprotein, multi drug resistance, type 1 transporter |
Special Carriers | selective, saturable, inhibitable |
Facilitated Diffusion | transmembrane carrier proteins undergo conformational changes; large molecules; faster than passive diffusion; does not require energy; saturable; competition for carrier protein |
Active Transport | carrier proteins span the membrane; energy dependent; across a concentration gradient; can be saturated; selective |
Endo/Exocytosis | large size drugs; in/out of cell |
Factors Influencing Absorption | expression of p-glycoprotein; contact time; total surface area; blood flow; pH |
Weak Acids/Bases | acidic drugs release protons forming a charged anion; weak bases release a proton; uncharged drugs pass through; lower pKa of a drug --> more acidic |
Weak Acids/Bases | uncharged form more lipid soluble; weak acids excreted faster in alkaline urine; weak bases excreted faster in acidic urine |
P-glycoprotein | efflux; expression decreases absorption; associated with drug resistance |
Bioavailability | IV drugs = 100%; converted to oral 50%; PO drugs = first pass metabolism |
Bioavailability factors influencing | solubility of drug = hydrophilic drugs poorly absorbed --> not soluble in aqueous body fluids, cannot reach cells chemical instability = in stomach pH; GI tract enzymes Nature of drug formulation --> effects dissolution and rate of absorption |
Capillary Permeability | slit junctions --> large protein bound; NOT BRAIN (undergo active transport) tight junctions prevents protein bound and hydrophilic --> form BBB lipid soluble drugs readily penetrate CNS |
Protein Binding ** | plasma proteins: albumin = major drug binding protein --> keeps drug in blood |
Protein Binding | tissue proteins: drugs in tissues and tissue reservoirs = source of drug |
Volume of Distribution | fluid volume required to contain the entire drug in body at same concentration measured in plasma |
"Apparent" volume of distribution | ratio of total amount in body vs. drug plasma concentration |
High Vd | lots of drug in tissue; extravascular and lipophilic |
Low Vd | lots of drug in blood; size MW, plasma, hydrophilic |
Factors affecting Vd ** | 1) size (MW): high MW drugs remain in plasma, low VD 2) plasma protein; binding/extravascular --> plasma (same water) = low VD; extravascular = high vd 3) hydrophilic = low vd; lipophilic = high vd 4) capillary permeability |